Abstract
Introduction Skin neglected tropical diseases (NTDs), are endemic and under-diagnosed in many lower-income communities. The objective of this study was to determine the prevalence of skin NTDs and fungal infections in two primary schools and a community setting in rural Togo.
Method This was a cross-sectional study that took place between June-October 2021. The two primary schools are located on the outskirts of Lomé, the capital city. The community setting was Ndjéi, in north-east Togo. The choice of schools and village was random. Dermatologists examined the skin of study participants. Diagnosis of skin NTDs were made clinically.
Results A total of 1401 individuals were examined, 954 (68.1%) from Ndjéi community, and 447 (31.9%) were children in the schools. Cutaneous skin infections were diagnosed in 438 (31.3%) participants, of whom 355 (81%) were in community settings. There were 105 observed skin NTDs (7.5%), including 20 in schools (6.7% of school participants) and 85 (9.4%) in the community. Across all settings 68 (6.7%) NTDs were in children, and 37 (9.7%) in adults. In addition, there were 333 observed mycoses (23.4% prevalence). The main cutaneous NTDs diagnosed were scabies (n=86; 6.1%) and yaws (n=16, 1.1%). The prevalence of scabies in schools was 4.2%, and 7.2% in the rural community. One case of leprosy was diagnosed in each school and the rural community, and one Buruli Ulcer case in the community. In the school setting, five (6%) children with a skin NTD reported being stigmatised, four of whom had refused to attend school because of their dermatosis. In Ndjéi, 44 (4.6%) individuals reported having experienced stigma and 41 (93.1%) of them missed at least one day of school or work.
Conclusion This study shows that the burden of scabies and other skin infections is high in the school and rural community settings in Togo, with associated presence of stigma. Improved health promotion and education across institutional and community settings may reduce stigma and encourage early reporting of skin infection cases to a health facility.
Author summary This article is a group of conditions called skin Neglected Tropical Diseases (NTDs). The study takes place in Togo, West Africa. There is very little evidence around how widespread NTDs are in Togo. Local dermatologists carried out skin examinations of students in two schools on the edge of Lomé, the capital city. They also examined skin of community residents in rural Togo, in the north-east of the country. We show how the prevalence of fungal skin disease is very high, and also diagnosed numerous cases of scabies (one of the skin NTDs). Cases of leprosy and Buruli Ulcer were also found. Additionally, there were high levels of reported stigma. Our findings show how addressing this burden of disease is vital to improve individual and population health, but also to reduce the socio-economic consequences of these treatable conditions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The project received a Business Development Grant of £10,000 GBP from the University of Southampton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the "Togo Bioethics Committee for Health Research (reference: 012/2021/CBRS of 5 May 2021)", and also by the University of Southampton ethics committee (reference ERGO 63498).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data will be available from the University of Southampton public repository.
